Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-TNF antibodies, compositions, and methods for the treatment of active ankylosing spondylitis

Anti-TNF antibodies, compositions, and methods for the treatment of active ankylosing spondylitis

US Patent 11014982 · Granted May 25, 2021

Estimated economic value: $196,721,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Safe and effective method of treating psoriatic arthritis with anti-IL23 specifi2025
Anti-TNF antibodies, compositions, and methods for the treatment of active Ankyl2025
Anti-TNF antibodies, compositions, and methods for the treatment of active Ankyl2025
Anti-TNF antibodies, compositions, and methods for the treatment of active Ankyl2025
Anti-TNF antibodies, compositions, and methods for the treatment of active Ankyl2025
Anti-TNF antibodies, compositions, and methods for the treatment of active ankyl2024
Anti-TNF antibodies, compositions, and methods for the treatment of active ankyl2024
Anti-TNF antibodies, compositions, and methods for the treatment of active ankyl2024
Anti-TNF antibodies, compositions, and methods for the treatment of active ankyl2024
Monolithic intravaginal rings comprising progesterone and methods of making and 2022
Method for treating pre-type 1 diabetes in a human subject2021
Methods for the treatment of active Psoriatic Arthritis2021